Breezehaler

DEVICE2 trials

Sponsors

GlaxoSmithKline, University of Saskatchewan

Conditions

AsthmaPulmonary Disease, Chronic Obstructive

Phase 4

Study of Inhaler Device Attributes Investigating Critical and Overall Errors, Ease of Use, and Preference Between a Number of Inhaler Devices

CompletedNCT02184624

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2014-08-28End: 2015-07-31Updated: 2017-05-23

Duration of Long Acting Muscarinic Antagonist (LAMA) Bronchoprotection Against Methacholine Challenge

CompletedNCT02622243

University of SaskatchewanAsthma

Start: 2015-11-30End: 2016-03-31Updated: 2016-04-20

Related Papers

Duration of bronchoprotection of the long-acting muscarinic antagonists tiotropium & glycopyrronium against methacholine-induced bronchoconstriction in mild asthmatics.

2016-07-3015 citations